|
David has a degree in Natural Sciences, specialising in genetics, from the University of Cambridge, which included additional studies in biochemistry, molecular cell biology, organic chemistry, mathematics and geology. Following his degree, David went to study at the University of Oxford where he was awarded a DPhil for his research on the nuclear architecture of telomeres and how changes in nuclear organisation affect recombination. He then moved to the National Cancer Institute, part of the National Institutes of Health (NIH) in Bethesda, Maryland, USA, as an International Visiting Fellow. |
|
David Eyre
TRAINEE
ATTORNEY |
His studies at NIH included mapping the genome-wide DNA damage caused by anti-cancer chemotherapeutic drugs and screening for novel chemotherapeutic drugs, in particular topoisomerase II inhibitors. Following moving into the patents profession as a trainee, David attended Queen Mary, University of London to study for the Certificate in Intellectual Property Law, which he passed with Merit.
|
David has particular experience in prosecuting patent applications for DNA and RNA molecular cloning technologies, nucleotide sequencing, microarray technologies, detection and screening for biomarkers for disease states, analytical apparatus (both real-time and sample based), pharmaceuticals, medical devices, microbial bioreactors and water purification apparatus. He has also been involved in drafting patent applications relating to biomarkers for disease state and prognosis, apparatus for real-time chemical analysis and for potential targets for cancer therapy.
Email
|
